The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Junzo Nojima

Laboratory for Clinical Investigation

Osaka University Hospital

Suita

Osaka 565-0871

Japan

[email]@*.med.osaka-u.ac.jp

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Laboratory for Clinical Investigation, Osaka University Hospital, Suita, Osaka 565-0871, Japan. 2001 - 2008

References

  1. Tissue factor expression on monocytes induced by anti-phospholipid antibodies as a strong risk factor for thromboembolic complications in SLE patients. Nojima, J., Masuda, Y., Iwatani, Y., Suehisa, E., Futsukaichi, Y., Kuratsune, H., Watanabe, Y., Takano, T., Hidaka, Y., Kanakura, Y. Biochem. Biophys. Res. Commun. (2008) [Pubmed]
  2. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus. Nojima, J., Masuda, Y., Iwatani, Y., Kuratsune, H., Watanabe, Y., Suehisa, E., Takano, T., Hidaka, Y., Kanakura, Y. Rheumatology. (Oxford) (2008) [Pubmed]
  3. Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies--Co-existence of these antibodies enhances ADP-induced platelet activation in vitro. Nojima, J., Kuratsune, H., Suehisa, E., Kitani, T., Iwatani, Y., Kanakura, Y. Thromb. Haemost. (2004) [Pubmed]
  4. Acquired activated protein C resistance is associated with the co-existence of anti-prothrombin antibodies and lupus anticoagulant activity in patients with systemic lupus erythematosus. Nojima, J., Kuratsune, H., Suehisa, E., Kawasaki, T., Machii, T., Kitani, T., Iwatani, Y., Kanakura, Y. Br. J. Haematol. (2002) [Pubmed]
  5. Acquired activated protein C resistance associated with anti-protein S antibody as a strong risk factor for DVT in non-SLE patients. Nojima, J., Kuratsune, H., Suehisa, E., Kawasaki, T., Machii, T., Kitani, T., Iwatani, Y., Kanakura, Y. Thromb. Haemost. (2002) [Pubmed]
  6. Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Nojima, J., Kuratsune, H., Suehisa, E., Futsukaichi, Y., Yamanishi, H., Machii, T., Iwatani, Y., Kanakura, Y. Clin. Chem. (2001) [Pubmed]
  7. Anti-prothrombin antibodies combined with lupus anti-coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus. Nojima, J., Kuratsune, H., Suehisa, E., Futsukaichi, Y., Yamanishi, H., Machii, T., Kitani, T., Iwatani, Y., Kanakura, Y. Br. J. Haematol. (2001) [Pubmed]
 
WikiGenes - Universities